Page last updated: 2024-10-30

leflunomide and Familial Mediterranean Fever

leflunomide has been researched along with Familial Mediterranean Fever in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Familial Mediterranean Fever: A group of HEREDITARY AUTOINFLAMMATION DISEASES, characterized by recurrent fever, abdominal pain, headache, rash, PLEURISY; and ARTHRITIS. ORCHITIS; benign MENINGITIS; and AMYLOIDOSIS may also occur. Homozygous or compound heterozygous mutations in marenostrin gene encoding PYRIN result in autosomal recessive transmission; simple heterozygous, autosomal dominant form of the disease also exists with mutations in the same gene.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bodur, H1
Seçkin, U1
Eser, F1
Ergül, G1
Seçkin, S1

Other Studies

1 other study available for leflunomide and Familial Mediterranean Fever

ArticleYear
Coexistence of familial Mediterranean fever and psoriasis in a patient with seronegative spondyloarthropathy.
    Rheumatology international, 2008, Volume: 29, Issue:1

    Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Colchicine; Drug Therapy,

2008